Autonomix Medical (AMIX) Research & Development (2022 - 2025)

Autonomix Medical (AMIX) has reported Research & Development for 4 consecutive years, with $1.7 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Research & Development rose 65.13% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $7.2 million, a 87.0% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 112.36% from the prior year.
• Research & Development was $1.7 million for Q4 2025 at Autonomix Medical, down from $2.4 million in the prior quarter.
• Over five years, Research & Development peaked at $2.4 million in Q3 2025 and troughed at $199000.0 in Q4 2022.
• A 4-year average of $1.0 million and a median of $954000.0 in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 245.23% in 2023 and soared 51.97% in 2024, its largest moves.
• Over 4 years, Research & Development stood at $199000.0 in 2022, then jumped by 245.23% to $687000.0 in 2023, then soared by 51.97% to $1.0 million in 2024, then surged by 65.13% to $1.7 million in 2025.
• The last three Research & Development figures came in at $1.7 million (Q4 2025), $2.4 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.